Study suggests alternative to using preservatives in nasal spray

Nov 15, 2010

A preservative-free alternative to standard nasal sprays -- which routinely use preservatives that can cause unwanted side effects, such as allergies or damage to the mucosal lining of the nose -- was found to be both safe and well-tolerated, in a short-term study from the Stanford University School of Medicine.

The alternative acidified solution also maintained in the applicator bottle without the use of the chemical preservatives, according to the study, which will be published Nov. 15 in the Archives of Otolaryngology-Head & Neck Surgery.

"There is another way that you can preserve nasal sprays that is safe for consumer use," said Peter Hwang, MD, professor of otolaryngology and co-author of the study. "This also has potential for eye drops, medicated sprays, eardrops."

Stanford researchers decided to test the safety of the new method of maintaining sterility, which is patented by an ophthalmologist in Los Altos, Calif., as an alternative to the wide use of preservatives in everything from over-the-counter nasal sprays to medicated sprays and eye drops. Scientific evidence has shown that the preservatives used, such as benzalkonium chloride and phenylcarbinol, can damage human and animal tissues.

Researchers compared the use of a saline nose spray that had been acidified by hydrochloric acid to a pH of 2.5 and then buffered by low concentrations of citric acid with the commonly used over-the-counter saline nose spray Ocean Spray, which contains both benzalkonium chloride and phenylcarbinol.

Twenty healthy subjects used the preservative-free saline spray in each nostril twice a day for a week followed by a weeklong "washout period" and then another weeklong use of the over-the-counter commercial product. Each subject underwent a nasal endoscopic exam and filled out an extensive questionnaire — the Sino-Nasal Outcome Test, or SNOT — at the end of each week of use.

The open-applicator bottle was also tested for bacterial growth. None was found in either of the spray solutions. No differences were found in symptom reporting or in the endoscopy findings between the preservative-free versus the preservative-containing spray.

"Of those analyzed, we believe that the most important symptoms for determining the safety and tolerance of the preservative-free acidified solution nasal spray are nasal burning, smell disturbance, taste disturbance, nasal bleeding, purulent rhinorrhea [runny nose with pus], sore throat, need to blow nose, sneezing, runny , postnasal discharge, thick nasal discharge, ear fullness, ear pain and facial pain or pressure," the authors write. "There were no discernible differences in these symptoms between the two nasal sprays used."

Explore further: Hormonal therapy for transsexualism safe and effective

add to favorites email to friend print save as pdf

Related Stories

Saline nasal wash helps improve children's cold symptoms

Jan 21, 2008

A saline nasal wash solution made from processed seawater appears to improve nasal symptoms and may help prevent the recurrence of respiratory infections when used by children with the common cold, according to a report in ...

Bacterial spray can help children with glue ear

Mar 29, 2010

Many children have long-term problems with fluid in the middle ear, and sometimes surgery is the only way to shift it. However, a bacterial nasal spray can have the same effect in some children, reveals a thesis from the ...

Recommended for you

Hormonal therapy for transsexualism safe and effective

22 hours ago

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma lets Elan takeover bid expire

Jun 18, 2013

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

FDA approves new silicone breast implants

Jun 17, 2013

(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

User comments : 0

More news stories

No danger of cancer through gene therapy virus

In fall 2012, the European Medicines Agency (EMA) approved the modified adeno-associated virus AAV-LPL S447X as the first ever gene therapy for clinical use in the Western world. uniQure, a Dutch biotech company, had developed ...

Antioxidant shows promise in Parkinson's disease

Diapocynin, a synthetic molecule derived from a naturally occurring compound (apocynin), has been found to protect neurobehavioral function in mice with Parkinson's Disease symptoms by preventing deficits in motor coordination.

Paralysed with fear: The story of polio

Thanks to vaccination, polio has been pushed to the brink of extinction – but can we finish the job? This is one of the big questions which a Bristol academic addresses in his new book, published next week.

EUROnu project recommends building Neutrino Factory

(Phys.org) —The European Union's Seventh Framework Programme, EUROnu, has submitted its findings to a panel at CERN. Charged with choosing a project to study the nature of matter and antimatter, the project ...